openPR Logo
Press release

Implantable Cardiac Monitors Market is Expected to Play a Significant Role in Bringing a $ 678.3 Million Boost to the Global Economy

03-14-2019 09:28 AM CET | Health & Medicine

Press release from: Allied Market Research

Implantable Cardiac Monitors Market

Implantable Cardiac Monitors Market

Improved diagnostics and the availability of new monitoring devices have revolutionized the field of medical diagnostics in the past decades. Moreover, development in sophisticated devices in area of medical cardiology and progression of their adoption in both hospitals & homecare are of key importance for the market growth.

The Implantable Cardiac Monitors Market is projected to grow at a CAGR of 7.4% from 2017 to 2023 and reach $ 678.3 million by 2023. Heart arrhythmia marking almost half of market share in 2016.

An implantable cardiac monitor helps doctors assess the patient's health in relation to cardiac rhythm. This device aids in the treatment of heart patients, so that the patient has a working heart. It is used to monitor serious heart conditions such as heart attack, atrial fibrillation, and recent signs of heart attack. Due to the increased use of advanced batteries with durable battery life, the implantable loop recorder or heart monitor can be used to continuously monitor the patient for almost two to three years. This is ideal for patients requiring long-term continuous monitoring.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4517

The report provides a comprehensive analysis of the key players operating in the global implantable cardiac monitors market such as

• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Edwart
• General Electric Company
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic plc
• Nihon Kohden Corporation
• Phoenix Heart Center

The other players of the global implantable cardiac monitors market include Astellas Pharma, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Inc., ReliantHeart Inc., Abiomed, Inc., Basilea Pharmaceutical Ltd., Berlin Heart GmbH, Schiller AG, and Jarvik Heart, Inc.

Atrial fibrillation accounts for approximately one-third of the total implantable cardiac monitor market in 2016 and is expected to remain in place throughout the forecast period.

The hospitals sector accounted for about two-thirds of the market share in 2016 and are expected to remain in force during the forecast period. This is due to the use of cardio monitoring devices in hospitals for acute care, non-acute care and non-treatment purposes.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4517

Key Findings of the Implantable Cardiac Monitors Market:
• The epilepsy & unexplained falls are anticipated to grow at a steady rate during the analysis period.
• U.S. was the major shareholder in the North American implantable cardiac monitors market, accounting for the highest share in 2016.
• China occupied one-sixth share of the total Asia-Pacific implantable cardiac monitors market in 2016, and is expected to register a CAGR of 9.4% from 2017 to 2023.
• The cardiac centers & clinics segment witnessed the highest growth, and is anticipated to grow at a CAGR of 8.4% from 2017 to 2023.
• In terms of volume, the global implantable cardiac monitors market is forecasted to reach 261 thousand units by 2023 at a CAGR of 10.3% from 2017-2023.

In 2016, Asia-Pacific and LAMEA collectively accounted for nearly one-fifth share of the market, and are expected to continue this trend throughout the forecast period. Increase in awareness regarding cardiac monitoring; availability of cardiac monitors specifically in China, India, and the other developing economies and surge in prevalence of the cardiac diseases drive the market growth.

Moreover, the massive target population and growth in economy catering to the establishment of healthcare facilities boost the growth of the market.

Access Full Summery @ https://www.alliedmarketresearch.com/implantable-cardiac-monitors-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Cardiac Monitors Market is Expected to Play a Significant Role in Bringing a $ 678.3 Million Boost to the Global Economy here

News-ID: 1653681 • Views: 365

More Releases from Allied Market Research

Prenatal Vitamin Supplements Market Analysis of The Current and Emerging Trends
Global Prenatal Vitamin Supplements Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Prenatal Vitamin Supplements Market by Dosage Forms (Capsule, Powder and
Multiple Myeloma Market Analysis of Top industry Scenario
Global Multiple Myeloma Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Multiple Myeloma Market by Therapeutics Type [Chemotherapy and Other Drugs (Traditional
Osteoarthritis Pain Drugs Market to Boost Revenue with Massive Growth
Global Osteoarthritis Pain Drugs Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Osteoarthritis Pain Drugs Market by Drug Class (NSAIDs, Opioids, Viscosupplements,
Ablation Technologies Market Size, Analysis, Share, Research, impact of COVID-19 …
Rising incidences of symptoms such as cancer and cardiac ailments is expected to foster the demand for ablation procedures. Technological advancements to design high-end products and growing demand for treatment procedures, which are minimally invasive are expected to boost the ablation technologies market. Furthermore, rising count of aging population having higher risk of target diseases is another vital factor driving the demand for ablation procedures. Download Free Sample Report@ https://www.alliedmarketresearch.com/request-sample/1066 Ablation Technologies

All 5 Releases


More Releases for Implantable

Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025. For In depth Information Get
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new
Implantable Ports Market - Competition Framework 2017-2025
Global Implantable Ports Market: Overview Implantable ports, which are long, narrow, soft, and thin plastic tubes with a rubber disc at the end, are frequently inserted into chemotherapy patients in order to administrate drugs to individuals. Also called as portacaths or subcutaneous, the diameter of implantable ports ranges from 2.5 cm to 4 cm and are highly useful for patients receiving treatment into a vein. Blood transfusions, chemotherapy, intravenous (IV) fluids,
Implantable Ports Market Sharp Rise over 2025
Global Implantable Ports Market: Overview Implantable ports, which are long, narrow, soft, and thin plastic tubes with a rubber disc at the end, are frequently inserted into chemotherapy patients in order to administrate drugs to individuals. Also called as portacaths or subcutaneous, the diameter of implantable ports ranges from 2.5 cm to 4 cm and are highly useful for patients receiving treatment into a vein. Blood transfusions, chemotherapy, intravenous (IV) fluids,
Implantable Medical Devices Market: A comprehensive survey
The global market for implantable medical devices market is experiencing an increased demand due to rampant technological advancements. The market is highly consolidated as the top four players account for a little over 50% of the market share making it difficult for new players to enter the market. Moreover, the research excellence attained by these established players overpowers the ability of other small and medium sized players to innovate and
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of